Literature DB >> 19297632

Attention deficit hyperactivity disorder in prison: a treatment protocol.

Kenneth L Appelbaum1.   

Abstract

Prescribing controlled substances in correctional settings can create challenges for security, nursing, and psychiatric staff. Some inmates, including those with functionally significant attention deficit hyperactivity disorder (ADHD), however, can benefit from such treatment. This article describes the development of a protocol for the treatment of prison inmates with ADHD that attempted to address a broad range of concerns including disparate diagnostic and treatment standards among prison psychiatrists, conflicts between stakeholders, and medication misuse and substance abuse among inmates. The protocol provides criteria in four main areas: diagnosis, current functional impairment, treatment in general, and treatment with stimulants. Stakeholders had mixed reactions to the protocol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297632

Source DB:  PubMed          Journal:  J Am Acad Psychiatry Law        ISSN: 1093-6793


  4 in total

1.  Screening for ADHD Symptoms among Criminal Offenders: Exploring the Association with Clinical Features.

Authors:  Enrico Capuzzi; Martina Capellazzi; Alice Caldiroli; Francesca Cova; Anna Maria Auxilia; Paola Rubelli; Ilaria Tagliabue; Francesco Giuseppe Zanvit; Gianluca Peschi; Massimiliano Buoli; Massimo Clerici
Journal:  Healthcare (Basel)       Date:  2022-01-18

Review 2.  ADHD and offending.

Authors:  Susan Young; Kelly Cocallis
Journal:  J Neural Transm (Vienna)       Date:  2021-02-04       Impact factor: 3.850

3.  Perceptions and Attitudes of Correctional Staff Toward ADHD-A Challenging Disorder in Everyday Prison Life.

Authors:  Anna Buadze; Nadine Friedl; Roman Schleifer; Susan Young; Andres Schneeberger; Michael Liebrenz
Journal:  Front Psychiatry       Date:  2021-01-28       Impact factor: 4.157

Review 4.  Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical Issues.

Authors:  Michael Weightman; Ranjit Kini; Robert Parker; Mrigendra Das
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.